172 related articles for article (PubMed ID: 31448222)
21. Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection.
Zhang X; Bai Y; Xu L; Zhang B; Feng S; Xu L; Zhang H; Xu L; Yang P; Niu T; Zheng S; Liu J
Hepatol Int; 2019 Nov; 13(6):715-725. PubMed ID: 31531761
[TBL] [Abstract][Full Text] [Related]
22. An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma.
Hu Y; Sun H; Zhang H; Wang X
Front Oncol; 2020; 10():1189. PubMed ID: 32850343
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
[No Abstract] [Full Text] [Related]
25. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.
Gu XF; Shi CB; Zhao W
Int J Clin Exp Pathol; 2019; 12(6):2173-2183. PubMed ID: 31934040
[TBL] [Abstract][Full Text] [Related]
27. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
28. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma.
Xie H; Liu S; Zhang Z; Chen P; Tao Y
J Cancer; 2020; 11(19):5768-5781. PubMed ID: 32913470
[TBL] [Abstract][Full Text] [Related]
29. A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy.
Yantong Y; Shan L; Zhijie C; Youwei Z
Eur J Surg Oncol; 2018 Oct; 44(10):1595-1602. PubMed ID: 30041973
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis.
Yan Y; Lu Y; Mao K; Zhang M; Liu H; Zhou Q; Lin J; Zhang J; Wang J; Xiao Z
Hepatol Int; 2019 Sep; 13(5):618-630. PubMed ID: 31321712
[TBL] [Abstract][Full Text] [Related]
31. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
32. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
[TBL] [Abstract][Full Text] [Related]
33. A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
Lin Z; Cai YJ; Chen RC; Chen BC; Zhao L; Xu SH; Wang XD; Song M; Wu JM; Wang YQ; Zhou MT; Shi KQ
Clin Chim Acta; 2017 Jun; 469():171-179. PubMed ID: 28365450
[TBL] [Abstract][Full Text] [Related]
34.
Chen J; Cao J; Wang P; He X
Oncol Lett; 2020 Oct; 20(4):70. PubMed ID: 32863903
[TBL] [Abstract][Full Text] [Related]
35. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
[TBL] [Abstract][Full Text] [Related]
36. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
[TBL] [Abstract][Full Text] [Related]
37. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma.
Li J; Zhou J; Yang PH; Xia Y; Shi YH; Wu D; Lv G; Zheng W; Wang K; Wan XY; Lau WY; Wu MC; Fan J; Shen F
Eur J Cancer; 2016 Jul; 62():86-95. PubMed ID: 27232330
[TBL] [Abstract][Full Text] [Related]
38. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H
Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
40. Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes.
Liao H; Chen W; Dai Y; Richardson JJ; Guo J; Yuan K; Zeng Y; Xie K
Front Oncol; 2019; 9():883. PubMed ID: 31572677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]